Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selective suppression of humoral immunity by antineoplastic drugs.

× No keyword cloud information.

9 in total

1. Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer.

Authors: E Tichatschek; C C Zielinski; C Müller; P Sevelda; E Kubista; K Czerwenka; J Spona; H Wolf; M M Eibl
Journal: Cancer Immunol Immunother Date: 1988 Impact factor: 6.968

2. Specific suppression of antibody rebound after extracorporeal immunoadsorption. I. Comparison of single versus combination chemotherapeutic agents.

Authors: D S Terman; R Garcia-Rinaldi; B Dannemann; D Moore; C Crumb; A Tavel; R Poser
Journal: Clin Exp Immunol Date: 1978-10 Impact factor: 4.330

3. The effect of several immunomodulating agents on a model of humoral and cell mediated immunity in the mouse [proceedings].

Authors: J Bruin; J Cottney; D K Gemmel; A J Lewis
Journal: Br J Pharmacol Date: 1979-05 Impact factor: 8.739

4. Selective effects of immunosuppressive agents against the delayed hypersensitivity response and humoral response to sheep red blood cells in mice.

Authors: N S Doherty
Journal: Agents Actions Date: 1981-05

5. Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization.

Authors: J Cottney; J Bruin; A J Lewis
Journal: Agents Actions Date: 1980-09

6. Enhancement and inhibition of immunological mechanisms by immunosuppressive agents. I. Dose effect on priming and generation of memory to a bacterial antigen.

Authors: A J Macario; E Conway de Macario
Journal: Clin Exp Immunol Date: 1978-02 Impact factor: 4.330

7. Modulation of the immune system in the mouse. 2. Drug administration following antigen sensitization.

Authors: J Cottney; J Bruin; A J Lewis
Journal: Agents Actions Date: 1980-04

8. Phase I study of antilipopolysaccharide human monoclonal antibody MAB-T88.

Authors: R Daifuku; K Haenftling; J Young; E S Groves; C Turrell; F J Meyers
Journal: Antimicrob Agents Chemother Date: 1992-10 Impact factor: 5.191

9. Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy.

Authors: C C Zielinski; C Müller; E Tichatschek; P Aiginger
Journal: Br J Cancer Date: 1989-11 Impact factor: 7.640

9 in total